US EditionPublished • loading... • Updated
Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-Plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer's Disease Research
Alamar’s new multiplex blood test measures five key Alzheimer’s biomarkers in one sample to support early detection and precision diagnosis, available now via Technology Access Program.
- Alamar Biosciences launched the Research Use Only NULISAqpcr AD 5-plex Assay, available today as a service through its Technology Access Program.
- Designed to empower the neuroscience community, Alamar’s NULISAqpcr AD 5-plex Assay measures Alzheimer’s Association–recommended biomarkers from a single blood or plasma sample.
- Using its proprietary NULISA technology and the ARGO HT System, Alamar's assay consolidates BD-pTau217, Aβ42, NfL, GFAP and APOE4 into a multiplexed format delivering ultra-high sensitivity and specificity.
- By consolidating tests into one panel, researchers and clinicians reduce the need for multiple single-plex assays, creating a powerful tool for translational and clinical research and beyond Alzheimer's to other neurodegenerative disorders.
- Because blood-based biomarkers are redefining research, Alamar says the NULISAqpcr AD 5-plex Assay supports precision diagnosis and therapy eligibility with cheaper, accessible early detection.
Insights by Ground AI
19 Articles
19 Articles
Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research
Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer's Disease Research
·India
Read Full Article
Alamar Biosciences Announces Launch of NULISAqpcr AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research
FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ — Alamar Biosciences, Inc. (“Alamar”), a leader in precision proteomics dedicated to advancing the early detection of disease, is proud to announce the launch of its Research Use Only (RUO) NULISAqpcr™ AD 5-plex Assay. This innovative solution enables simultaneous quantitative measurement of five critical blood-based biomarkers relevant to the […] The post Alamar Biosciences Announces Launch of NULISAq…
Coverage Details
Total News Sources19
Leaning Left3Leaning Right1Center7Last UpdatedBias Distribution64% Center
Bias Distribution
- 64% of the sources are Center
64% Center
L 27%
C 64%
Factuality
To view factuality data please Upgrade to Premium
